In human trials of over 22 documented patients, our platform technology has shown clinical effectiveness in growing layers of tissue, resolving a range of slow or non-healing open wounds. This includes diabetic leg ulcers and burn wounds, which have previously been non-responsive to standard clinical therapy and diagnosed for amputations.
Our platform technology consists of a combination two part system. Gen-ray® accelerates tissue growth via our proprietary advanced photonics technology and Hemastyl R® rapidly grows muscle, connective, vascular, dermal and epidermal tissues via our proprietary wound healing substrate, eliminating grafts.
There's much to see and learn here about how Rapid Nexus is saving patients from receiving amputations.
So, take your time, look around, and contact us for information about our Telemedicine Wound Healing System.
Before: Non-healing, open wound, limb ischemia
After: Rapid tissue growth, circulation restoration
Keep up to date on our latest developments and product specials!